72
[1] http://www.infectiologie.com/UserFiles/File/spilf/recos/infections- urinaires-spilf.pdf, 59.
[2] Trivalle C. Antibiothérapie et p e r s o n n e s âgées. Antibiotiques 2004 ; 6(3):164-8.
[3] Veyssier P, Belmin J. Conduites à tenir dans les infections du sujet âgé : Elsevier Masson; 2004.
[4] Trivalle C, Chassagne P, Bouaniche M, Landrin I, Marie I, Kadri N, et al. Nosocomial febrile illness in the elderly: frequency, causes,
and risk factors. Archives of internal medicine. 1998; 158(14):1560-5.
[5] http://www.ces.ma/Documents/PDF/Autosaisines/2015/as20/avas20f.p df
[6] Neugarten B.L., « Age groups in American society and the rise of the
young old », Annals of the American Academy of Political and Social Sciences 1974;415,187-198.
[7] Lalive d’Épinay C., Spini D. Le grand âge : un domaine de recherche
récent Dans Gérontologie et société 2007/4 (vol. 30 / n° 123), pages 31 à 54.
[8] Suzman R., Riley W.M. « The oldest old », Milbank Memorial Fund
Quarterly Health and Society 1985;63,2,177-186.
[9] Kohli M., Rhein M., Guillemard A.M., Van Gusteren H. Time for
retirement. Comparatives studies of early exit from the labor force Cambridge, Cambridge University Press, 1991.
73
[10] Laslett P., A fresh map of life: the emergence of the third age, London,
Weidenfeld and Nicolson, 1989.
[11] Haut Commissariat au Plan 2006 ;6.
[12] 12. CERED- Haut Commissariat au Plan, 2005 ;59.
[13] Sajoux M., Nowik L. Autrepart, 2010
[14] Calculs des auteurs à partir des données de HCP 2005 ; 57-58
[15] Calculs effectués par les auteurs à partir des tableaux de répartition de la population selon le groupe quinquennal d’âge et le sexe, HCP 2005 ; 57-58.
[16] .Tabue Teguo M, Grasset L, Avila Funes JA, Genuer R, Proust
Lima C, Péres K, et al. Prevalence and Co-Occurrence of Geriatric
Syndromes in People Aged
[17] 75 Years and Older in France: Results from the Bordeaux Three-city Study. J Gerontol A Biol Sci Med Sci 2017 ;73(1):109-16.
[18] Fried LP, Tangen CM, Walston J, et al. Frailty in older adults:
evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-56.
[19] Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet
2013;381: 752-62.
[20] Lang PO, Trivalle C, Dramé M. La fragilité : mythe ou réalité ? NPG Neurologie- Psychiatrie-Gériatrie 2012;12:163-70.
74
[21] Cesari M, Landi F, Vellas B, et al. Sarcopenia and physical frailty:
two sides of the same coin. Front Aging Neurosci 2014;6:192.
[22] Michel JP., Lang PO. Quelles sont les relations entre sarcopénie et
fragilité ? NPG Neurologie - Psychiatrie - Gériatrie 2011;11:229-31.
[23] INSERM. Expertise collective Inserm. Rapport complet. Activité physique et prévention des chutes chez les personnes âgées. Rapport. In: Expertise collective. Paris : Les éditions Inserm ;2015[XII508p].
[24] Radloff LS. The CES-D Scale: A Self-Report Depression Scale for
Research in the General Population. Applied Psychological Measurement 1977 ;1 :385–401.
[25] Coulongeat, M., Pambet, M., Chassagne, P., & Gauvain, JB. Le
concept de fragilité chez la personne âgée : implications pour le rhumatologue. Revue Du Rhumatisme Monographies 2019.
[26] Lang PO, Aspinall R. Immunosenescence and herd immunity: with an
ever- increasing aging population do we need to rethink vaccine schedules? Expert Rev Vaccines 2012 ;11 :167—76.
[27] Govind S, Lapenna A, Lang PO, Aspinall R. Immunotherapy of
Immunosenescence: who, how and when? Open Longev Sci 2012;6.
[28] Weiskopf D, Weinberger D, Grubeck-Loebenstein B. The aging of
the immune system. Transpl Int 2009 ;2 :1041—50.
[29] Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis
75
[30] Yoshikawa TT. Epidemiology and unique aspects of aging and
infectious diseases. Clin Infect Dis 2000 ;30 :931—3.
[31] Lang PO, Govind S, Mitchell WA, Siegrist CA, Aspinall R. Vaccine
effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev 2011;10:389—95.
[32] Lang PO, Mitchell WA, Lapenna A, Pitts D, Aspinall R.
Immunological pathogenesis of main aged-related disease and frailty: role of immunosenescence. Eur Geriatric Med 2010 ;1 :112—21.
[33] Fulop T, Franceschi C, Hirokawa K, Pawelec G. Handbook of
immunosenescence: basic understanding and clinical applications. New York: Springer Science + Business Media BV 2009;1648.
[34] Lang P.O., Govind S., Aspinall R. L’immunosénescence. NPG
Neurologie-Psychiatrie-Gériatrie 2012;12(70), 171–181.
[35] Aspinall R, Pitts D, Lapenna A, Mitchell WA. Immunity in the
elderly: the role of the thymus. J Comp Path 2010;142: S111—5.
[36] Virgin HW, Wherry JE, Ahmed R. Redefining chronic viral
infection. Cell 2010;138:30—50.
[37] Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A.
Cytomegalovirus and human immunosenescence. Rev Med Virol 2009;19:47-56.
[38] Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human
nutrition, the gut microbiome and the immune system. Nature 2011;474:327—36.
76
[39] Lang PO, Samaras D, Samaras N. Testosterone replacement therapy
in reversing ‘‘andropause’’: what is the proof of principle? Rejuvenation Res 2012.
[40] Lang PO, Samaras D. Aging adults and seasonal influenza: does the
vitamin D status (h)arm the body? J Aging Res 2012;2012:806198.
[41] Fulop T, Larbi A, Witkowski JM, et al. Aging, frailty and age related
diseases.Biogerontology 2010;11:547-63.
[42] Franceschi C, Capri M, Monti D, et al. Inflammaging and
anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007;128:92-105.
[43] Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA.
Immunosenescence: implications for vaccination programmes in adults. Maturitas 2011;68:322-30.
[44] Panda A, Quian F, Mohanty S, et al. Age-associated decrease in TLR
function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010;184:2518-27.
[45] Siegrist CA, Aspinall R. B-cell responses to vaccination at the extreme
of age.Nature Immunol 2009;9:185-93.
[46] Lang PO, Govind S, Aspinall R. Reversing T cell immunosenescence:
why, who and how? Age (Dordr) 2013.
[47] Fulop T, Pawelec G, Castle P, Loeb M. Immunosenescence and
77
[48] Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the
prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunobiological space. Vaccine 2000;18:1717—20.
[49] Lang PO, Govind S, Mitchell WA, et al. Influenza vaccine
effectiveness in aged individuals: the role played by cell-mediated immunity. Eur Geriatr Med 2010;1:233—8.
[50] Ongradi J, Kovesdi V. Factors that may impact on immunosenescence: a appraisal. Immun Ageing 2010;7:7.
[51] Naylor K, Li G, Vallejo AN, et al. The influence of age on T cell
generation and TCR diversity. J Immunol 2005;174:7446—52.
[52] Mitchell WA, Lang PO, Aspinall R. Tracing thymic output in older
individuals.Clin Exp Immunol 2010;161:497—503.
[53] Chen JC, Lim FC, Wu Q, et al. Maintenance of naïve CD8 T- cells in
nonagerians by leptine IGFBP3 and T3. Mech Ageing Dev 2010;131:29—37.
[54] Ferrando-Martinez S, Ruiz-Mateos E, Hernandez A, et al.
Age-related deregulation of naive T-cell homeostasis in elderly humans. Age (Dordr) 2011;33:197—207.
[55] Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O’Fallon WM, Weyand CM. Value of immunological markers in predicting
responsiveness to influenza vaccination in elderly individuals. J Virol 2001;75:12182—7.
78
[56] Effros RB. Role of T lymphocyte replicative senescence in vaccine
efficacy.Vaccine 2007;25:599—604.
[57] Evans EJ, Esnouf RM, Manso-Sancho R, et al. Crystal structure of a
soluble CD28-Fab complex. Nat Immunol 2005;6:271—9.
[58] Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell
responses to antigen. Annu Rev Immunol 1993;11:191—212.
[59] Hüning T, Lücher F, Elfein K, et al. CD28 and IL-4: two heavyweights
controlling the balance between immunity and inflammation. Med Microbial Immunol 2010;199:239—46.
[60] Wikby A, Ferguson F, Forsey R, et al. An immune risk phenotype,
cognitive impairment and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol Biol Sci 2005;60A:556-65.
[61] Wikby A, Nilsson BO, Forsey R, et al. The immune risk phenotype is
associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 2006;127:695—704.
[62] Vallejo AN. CD28 extinction in human T-cells: altered func- tions and
the program of T-cell senescence. Immunol Rev 2005;205:158—69.
[63] Lang A, Brien JD, Nikolich-Zugich J. Inflation and long-term
maintenance of CD8 T cells responding to latent herpes virus depend upon establishment of latency and presence of viral antigens. J Immunol 2009;183:8077—87.
79
[64] Lang A, Brien JD, Messaoudi I, Nikolich-Zugich J. Age-related
dysregulation of CD8+ T cell memory specific for a per- sistent virus is independent of viral replication. J Immunol 2008;180:4848.
[65] Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of
clonically expended CD8 T cells reveal arepertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T-cells in very elderly. J Immunol 2006;176:2645—53.
[66] Bloomberg BB, Frasca D, Dunn-Walters D. Human B cell
senescence and pulmonary infections. Open Longev Sci 2012:6 [In press].
[67] Frasca D, Diaz A, Romera M, Landin AM, Blomberg BB. Age
effects on B cells and humoral immunity in humans. Ageing Res rev 2011;10:330—5.
[68] Haynes L, Eaton SM. The effect of age on the cognate function of
CD4+ T cells. Immunol Rev 2005; 205:220—8.
[69] Matzen LE, Jepsen DB, Ryg J, Masud T. Functional level at
admission is a predictor of survival in older patients admitted to an acute geriatric unit. BMC Geriatr. 2012;12:32.
[70] Bourdel-Marchasson I., Kraus F., Pinganaud G., Texier-Maugein J., Rainfray M., Emeriau J. Incidence sur un an et facteurs de risque
des infections nosocomiales bactériennes dans un service de médecine interne gériatrique. La Revue de Médecine Interne 2001 ; 22(11), 1056– 1063.
80
[71] RUBEN F.C., DEARWATER S.R., NORDEN C.W., KULLER L.H., GARTNER K. - Clinical infections in the noninstitutionalized
geriatric group: methods utilized and incidence of infections. The Pittsburg good health study. Am J Epidemiol. 1995;15:145-57.
[72] Forestier E. Actualités sur les infections urinaires et respiratoires
basses du sujet âgé. Les Cahiers de L’année Gérontologique 2014 ; 6(3),119-125.
[73] Faucher N, Billebaud T. Les infections urinaires du sujet âgé. Rev
Gériatrie 2000 ; 25 : 507-13.
[74] Gravey F., Cattoir V., De la Blanchardière A., Loggia G.
Épidémiologie bactérienne et profils de résistance aux antibiotiques
des échantillons urinaires du sujet âgé. Progrès En
Urologie,2016;26(13), 694–695.
[75] Drieux L. Caractéristiques des infections respiratoires basses chez les
sujets âgés.Antibiotiques,2010 ;12(4), ;190–196.
[76] Jackson ML, Nelson JC, Jackson LA. Risk factors for community acquired pneumonia in immunocompetent seniors. J Am Geriatr Soc 2009;57:882-8.
[77] Loeb M, Neupane B, Walter SD, Carusone SC, Lewis D, Krueger P, et al. Environmental risk factors for community-acquired pneumonia
hospitalization in older adults. J Am Geriatr Soc 2009;57:1036-40.
[78] Farhad R., Roger P. M., Levraut J., Declemy S., Dellamonica P.
Infections respiratoires des sujets âgés : intérêt d’une structure spécialisée. Antibiotiques 2007;9(4),233–236.
81
[79] Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV.
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990; 162:1316-23.
[80] Patey O, Yver O, Chaplain C, Dublanchet A, Lafaix C, Malkin JE.
Méningites bactériennes du sujet âgé. À propos de 74 observations. Méd Mal Infect 1988 ;18:381.
[81] Aronson SM, DeBuono BA, Buechner JS. Acute bacterial meningitis
in Rhode Island: a survey of the years 1976 to 1985. R I MedJ1991;74:33-6.
[82] Miller LG, Choi C. Meningitidis in older patient: how to diagnose and
treat a deadly infection. Geriatrics 1997;52:43-55.
[83] Trivalle C., Feteanu D. Septicémies et bactériémies en gériatrie, Rev.
Geriatr., 2001 ;26,23-6.
[84] Behrman RE, Meyers BR, Mendelson MH, Sacks HS, Hirschman SZ. Central nervous system infections in the elderly. Arch Intern Med
1989;149:1596-9.
[85] Gorse GJ, Thrupp LD, Nudleman KL, Wyle FA, Hawkins B, Cesario TC. Bacterial meningitis in the elderly. Arch Intern Med
1984;144:1603-7.
[86] Pirvu C, Iurasog G, Ardeleanu R, Onesciuc I, Gavrila I.
Particularités des méningites aiguës chez les personnes âgées. Sem Hôp Paris 1973;49:2143-9.
82
[87] Tunkel AR, Scheld WM. Acute meningitis. In: Mandell GL, Benett
JE, Dolin R, Eds. Principles and practice of infectious diseases, Vol. 1. New York: Churchill Livingstone 1995;831-65.
[88] Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, et al. Acute bacterial meningitis in adults. A review of
493 episodes. N Engl J Med 1993;328:21-8.
[89] Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S. Acute bacterial meningitis in adults. A 20year
overview. Arch Intern Med 1997;157:425-30.
[90] Isenberg H. Bacterial meningitis: signs and symptoms. Antibiot
Chemother 1992;45:79-95.
[91] Rasmussen HH, Sorensen HT, Moller-Petersen J, Mortensen FV, Nielsen B. Bacterial meningitis in elderly. Patients: clinical picture and
course. Age Ageing 1992;216-20,21.
[92] Le Moal G., Roblot F., Paccalin M., Pasdeloup T., Roblot P., Becq-Giraudon B. Particularités des méningites du sujet âgé. La Revue de
Médecine Interne 2000;21(10), 844–853.
[93] Klein NC, Damsker B, Hirschman SZ. Mycobacterial meningitis.
Retrospective analysis from 1970 to 1983. Am J Med 1985; 29-34,79
[94] Golliot F, Astagneau P, Cassou B et al. Nosocomial infection in
geriatric long- term and rehabilitation facilities: exploration in the development of the risk index for epidemiologic surveillance. Infect Control Hosp Epidemiol 2001;22,746-53.
83
[95] épidémiologiques, cliniques, thérapeutiques et évolutifs de l’infection à VIH chez le sujet âgé sénégalais. Les Cahiers de L’année Gérontologique 2014;6(3), 97-101.
[96] Manfredi R. HIV infection and advanced age emerging epidemiological, clinical and management issues. Ageing Res Rev 2004;3:31–54
[97] Collarino R., Lescure X., Vaillant L., de Villelongue C., Cabras O.
Service de maladies infectieuses, hôpital Bichat, Paris, France
[98] Schoevaerdts D, Verroken A, Huang T-D, et al. Multidrug-resistant
bacteria colonization amongst patients newly admitted to a geriatric unit: a prospective cohort study. J Infect 2012;65:109–18
[99] https://pepite-depot.univ-lille2.fr/nuxeo/site/esupversions/3d520270- 7821-4105-80f3-75be179e7dd9